Intus Healthcare Set To Launch Ovarian Cancer Device OvPlex In UK
Intus Healthcare has reached an exclusive distribution agreement with HealthLinx in February 2009 for the distribution of OvPlex in the UK and Republic of Ireland (ROI) with an
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.
In keeping with the streamlining focus of Oystar’s recent realignment strategy, Packaging Technologies and Aerofill Dawson will consolidate their operations into the Davenport, Iowa-based 200,000 square-foot facility. As